Hopeful mouse data suggest restoring the brain’s energy balance could do what decades of research have not: push Alzheimer’s into retreat.
For more than a century, treatments for Alzheimer’s disease have largely focused on slowing decline, not turning it around. But a new study from University Hospitals Cleveland Medical Center is quietly challenging that assumption, offering a different way of thinking about the disease. Now, it’s seen not just as toxic buildup in the brain, but as a crisis of energy.
In experiments involving mice and human brain tissue, researchers found that restoring balance to a molecule essential for cellular energy dramatically reversed Alzheimer’s-like damage [1]. The findings, published last week in Cell Reports Medicine, do not claim a cure. But they do reopen a door many thought was permanently closed.
The center of the study is NAD+, a molecule found in every cell of the body. It helps cells turn nutrients into usable energy and repair everyday damage. NAD+ is especially important in organs that work nonstop, including the brain.
Researchers examined two mouse models of Alzheimer’s alongside human Alzheimer’s brain tissue and found the same pattern: severe depletion of NAD+ [1].
“NAD+ naturally declines with age. When NAD+ falls below necessary levels, cells cannot effectively perform essential maintenance and survival functions,” said Dr Andrew A Pieper, director of the Brain Health Medicines Center at Harrington Discovery Institute.
The brain, which uses roughly 20% of the body’s total energy despite accounting for only about 2% of its weight, may be particularly vulnerable to this energy shortfall.
Rather than directly targeting amyloid plaques – the sticky protein clumps long blamed for Alzheimer’s – the team focused on restoring NAD+ balance. They used an experimental drug called P7C3-A20, designed to stabilize NAD+ levels without pushing them too high.
The results surprised even the researchers. In mice with early-stage disease, the treatment blocked Alzheimer’s from developing. In mice with advanced disease, it reversed hallmark brain changes, including amyloid and tau buildup, and fully restored cognitive function. Blood levels of phosphorylated tau 217, a key biomarker used in human Alzheimer’s research, also returned to normal [1].
“For more than a century, Alzheimer’s has been considered irreversible. Our experiments provide a proof of principle that some forms of dementia may not be inevitably permanent,” Pieper said.
The most striking detail is not just that symptoms improved, but how they improved. The reversal happened without directly attacking amyloid plaques, suggesting that brain degeneration may be driven as much by metabolic failure as by toxic accumulation.
Dr Charles Brenner, chief scientific advisor for Niagen, underscored why energy balance matters.
“The brain consumes around 20% of your body’s energy and has high demand for NAD+ for cellular energy production and DNA repair,” he said. NAD+, he added, helps neurons adapt to stress and supports long-term brain health.
This reframing could have implications beyond Alzheimer’s. Previous work from the same lab showed that restoring NAD+ balance sped recovery after severe traumatic brain injury, hinting at a broader role in neuroprotection.
Despite the excitement, the researchers are careful to draw clear boundaries. The study was conducted entirely in animal models.
“Alzheimer’s is a complex, multifactorial, uniquely human disease. Efficacy in animal models does not guarantee the same results in human patients,” Pieper said.
No drug has yet been tested in humans with the goal of reversing Alzheimer’s. The team also warned against assuming that over-the-counter NAD+-boosting supplements are a shortcut. Some supplements can push NAD+ levels too high, which in certain animal models has been linked to cancer risk.
“P7C3-A20, by contrast, enables cells to restore and preserve appropriate NAD+ balance under stress without driving NAD+ to excessively high levels,” Pieper noted. Anyone considering NAD+-modulating supplements, he added, should consult a physician.
While pharmaceutical translation remains years away, the study reinforces something less futuristic: the importance of brain resilience.
Pieper emphasized lifestyle measures already linked to lower dementia risk, including sufficient sleep, following a MIND or Mediterranean diet, staying physically and cognitively active, maintaining social connections, addressing hearing loss, protecting the head from injury, limiting alcohol and controlling cardiovascular risk factors such as high blood pressure and smoking.
These steps may not reverse Alzheimer’s, but they support the same principle highlighted by the study, which is to keep the brain’s systems balanced and resilient for as long as possible.
The research team plans to explore whether restoring brain energy balance could help other age-related neurodegenerative diseases. For now, the findings stand as a reminder that progress does not always come from attacking a disease head-on. Sometimes, it comes from asking a simpler question: what happens when the brain finally gets the energy it needs to heal?
